Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064
about
Exposure to the synthetic FXR agonist GW4064 causes alterations in gene expression and sublethal hepatotoxicity in eleutheroembryo medaka (Oryzias latipes)Pharmacophore-based discovery of FXR agonists. Part I: Model development and experimental validation.Conformational dynamics of human FXR-LBD ligand interactions studied by hydrogen/deuterium exchange mass spectrometry: insights into the antagonism of the hypolipidemic agent Z-guggulsterone.Development of time resolved fluorescence resonance energy transfer-based assay for FXR antagonist discoveryChallenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint WorkshopFarnesoid X receptor modulators: a patent review.Medicinal chemistry of farnesoid X receptor ligands: from agonists and antagonists to modulators.Characterizing ligands for farnesoid X receptor--available in vitro test systems for farnesoid X receptor modulator development.Combining self- and cross-docking as benchmark tools: the performance of DockBench in the D3R Grand Challenge 2.Role of farnesoid X receptor in cholestasis.Design, Synthesis, and Biological Evaluation of Novel Nonsteroidal Farnesoid X Receptor (FXR) Antagonists: Molecular Basis of FXR Antagonism.Antidiabetic sulfonylureas modulate farnesoid X receptor activation and target gene transcription.Simultaneous diastereo- and enantioseparation of farnesoid X receptor (FXR) agonists with a quinine carbamate-based chiral stationary phase.Using physics-based pose predictions and free energy perturbation calculations to predict binding poses and relative binding affinities for FXR ligands in the D3R Grand Challenge 2.
P2860
Q30494047-85910BB8-6308-44B2-B244-7F7C0F5F5071Q34054283-0BC35E66-7642-4805-9895-E798D8148E8FQ34065876-695AE9E9-0047-4C1E-9AC2-D6F9329ABF70Q34729209-DC1E5A36-6158-4285-8FEE-CB63861DD1A6Q36987260-02A96288-97DF-4DDD-8A48-AD2DAB60E8BDQ37766898-879DF9F3-7FAF-41DC-A7E9-5D337DDF35A6Q38014901-EB8568DB-C99B-4CBC-8FC3-E0546E2DB5E8Q38164798-54C3274B-501F-4008-A39C-D73A72B6FA14Q38608749-DF2EE709-48D5-474A-9327-CA1688180F6CQ38887864-953E9594-4A98-440F-958B-245FEC256009Q39005761-5A6AA57F-EB40-4AC4-8877-B78521ACA6CDQ39769377-E799889D-A033-4BEC-89E4-2A7000700FD6Q46739028-D51AEFE8-9F44-436C-B6D1-4338B087E605Q47614697-33A3A7CE-07F1-4C28-B92F-01B213A0BCD2
P2860
Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064
@ast
Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064
@en
Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064
@nl
type
label
Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064
@ast
Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064
@en
Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064
@nl
prefLabel
Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064
@ast
Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064
@en
Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064
@nl
P2093
P1476
Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064
@en
P2093
Aaron B Miller
David N Deaton
Derek J Parks
G Bruce Wisely
Harry B Marr
Jonathan Y Bass
Justin A Caravella
Katrina L Creech
Kevin P Madauss
P304
P356
10.1016/J.BMCL.2009.04.047
P407
P577
2009-04-18T00:00:00Z